Skip to content
Home/Companies/Biotech/Immatics
IM

Immatics

Biotech·Germany·Active·16yr hold

Immatics is a biotech company, headquartered in Germany.

Entry
2010
Hold
16yr
Status
Active
Est. EV
–

Who owns Immatics?

Immatics is currently owned by MIG Capital through MIG Fonds 8 (2009 vintage), since 2010. Across its history, Immatics has been through 3 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-07-03

MIG Capital
Most recent investor
MIG Capital
MIG Fonds 8 · 2009 · Evergreen
4 ownership periods · full history below

Key facts

HQGermany
SectorBiotech
StatusActive

Ownership history

4 ownership periods · co-invest detected

Active
Co-held by dievini Hopp BioTech holding, MIG Capital and Athos since 2006.
Co-invest · 4 holders · 2006 · present
dievini Hopp BioTech holding
dievini Hopp BioTech holdingActive
2006 · present · dievini Hopp BioTech holding (Evergreen Balance Sheet) · 2005 · Evergreen
MOIC
–
MIG Capital
MIG CapitalActive
2010 · present · MIG Fonds 8 · 2009 · Evergreen
MOIC
–
MIG Capital
MIG CapitalActive
2010 · present · MIG Fonds 5 · 2007 · Evergreen
MOIC
–
Athos
AthosActive
2020 · present · Athos Evergreen Life Sciences · 2001 · Evergreen
MOIC
–

More from MIG Fonds 8

Other portfolio companies in the same fund.

NFON
Exited 2018
TMTGermany· 2009
BioNTech
Exited 2021
BiotechGermany· 2008

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings